GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (STU:LMQ) » Definitions » Current Deferred Revenue

Oxford BioDynamics (STU:LMQ) Current Deferred Revenue : €0.00 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Oxford BioDynamics Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Oxford BioDynamics's current deferred revenue for the quarter that ended in Sep. 2024 was €0.00 Mil.

Oxford BioDynamics Current Deferred Revenue Historical Data

The historical data trend for Oxford BioDynamics's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Current Deferred Revenue Chart

Oxford BioDynamics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oxford BioDynamics Semi-Annual Data
Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oxford BioDynamics Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines